Latest Regulatory Clearance News

Imricor Medical Systems has secured CE Mark approval for its NorthStar Mapping System ahead of schedule, marking a pivotal shift to software-centric MRI-guided cardiac interventions across Europe and the Middle East.

Marvel Gold Limited has signed a binding agreement to sell its Mali gold assets to Anchises Capital for AUD 1.65 million, marking a strategic shift towards new growth opportunities in Tanzania.

Mayne Pharma disputes Cosette Pharmaceuticals’ attempt to terminate their acquisition agreement, with a key court hearing postponed to September and a crucial shareholder vote set for June 18.

PainChek has advanced its US regulatory approval process with a positive FDA meeting, setting the stage for a potential market debut of its pain assessment app in late 2025.

Mayne Pharma rebuffs Cosette's claim of a material adverse change in their merger scheme and secures FDA clearance on regulatory concerns, maintaining its commitment to the deal's completion.

Washington H. Soul Pattinson and Brickworks Limited have agreed to merge, creating a $14 billion ASX-listed entity and prompting key changes for Soul Patts' convertible notes. The deal simplifies their cross-shareholding and promises enhanced scale and diversification.

INOVIQ Limited has revealed promising data for its EXO-OC™ ovarian cancer screening test, demonstrating exceptional accuracy and flawless detection of early-stage cancers. This innovation could transform early diagnosis and treatment outcomes for women worldwide.

Soul Patts and Brickworks have announced a transformative merger to create Washington H. Soul Pattinson, a new $14 billion ASX-listed company that promises simplified ownership and enhanced shareholder value.

Washington H. Soul Pattinson and Brickworks Limited have agreed to merge, creating a $14 billion ASX-listed entity with enhanced scale, liquidity, and diversification. The deal simplifies a long-standing cross-shareholding and offers shareholders significant premiums and growth opportunities.

Washington H. Soul Pattinson and Brickworks Limited have agreed to merge, creating a $14 billion ASX-listed entity that promises greater scale, liquidity, and diversification for shareholders.

Credit Intelligence Ltd has announced a conditional agreement to sell its loss-making subsidiary Credit Intelligence Holding Limited for AUD 1.5 million, pending shareholder approval and regulatory clearances.

4DMedical has submitted its CT:VQ lung imaging technology for FDA clearance, aiming to disrupt the $1 billion US nuclear lung scan market with a non-nuclear, lower-cost alternative. Clinical studies show CT:VQ matches or exceeds existing nuclear imaging in accuracy and patient experience.